BackBharat Immunologicals & Biologicals Limited Overview

Bharat Immunologicals & Biologicals Limited Current Assets

Latest current assets for BIBCL.BO: $330M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$327.10M
↓ 43.76% YoYΔ $-254.47M vs prior year quarter

Peer trimmed avg / median

Loading

Bharat Immunologicals & Biologicals Limited Current Assets History

Loading

Bharat Immunologicals & Biologicals Limited vs. peers: Current Assets Comparison

Loading

Bharat Immunologicals & Biologicals Limited Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bharat Immunologicals & Biologicals Limited (BIBCL.BO) FAQ

As of the most recent data (September 2023), BIBCL.BO shows a current assets of $330M. That compares with $580M in the prior-year period — down 43.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIBCL.BO's current assets is now $330M (was $580M) — a 43.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bharat Immunologicals & Biologicals Limited is outperforming or lagging.

Tracking BIBCL.BO's current assets over time shows whether Bharat Immunologicals & Biologicals Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $330M That compares with $580M in the prior-year period — down 43.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Bharat Immunologicals & Biologicals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $330M) with ownership activity and broader fundamentals.